No image

ARK™ Oxcarbazepine Metabolite Assay

The ARK™ Oxcarbazepine Metabolite Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.

Details

Device typeMultiple anticonvulsant therapeutic drug monitoring IVD, reagent: A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay intended to be used for the quantitative measurement and therapeutic monitoring of multiple anticonvulsant drugs, also known as antiepileptic drugs which may include carbamazepine, lamotrigine, phenytoin, and primidone, in a clinical specimen.

FDA categoryEnzyme Immunoassay, Oxcarbazepine Metabolite

Device ID00858724003308

Catalog number5032-0001-00

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone5102706270

Emailcustomersupport@ark-tdm.com

Related products

Product	Model	Company	Device type
ARK™ Lamotrigine AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5023-0001-00	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
ARK™ Levetiracetam AssayArk Diagnostics IncLevetiracetam therapeutic drug monitoring IVD, reagent	5024-0001-00	Ark Diagnostics Inc	Levetiracetam therapeutic drug monitoring IVD, reagent
ARK™ Pregabalin II AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5059-0001-01	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
ARK™ Topiramate AssayArk Diagnostics IncMultiple-therapy therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA)	5015-0001-00	Ark Diagnostics Inc	Multiple-therapy therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA)